-
1.发明授权公开(公告)号：US07811792B2
公开(公告)日：2010-10-12
申请号：US12430847
申请日：2009-04-27
申请人： Eli Cohen , Roslyn Cohen
发明人： Eli Cohen , Roslyn Cohen
IPC分类号： C12P21/04
CPC分类号： C12Q1/56
摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II).
摘要翻译： 使用止血分析仪，如Thrombelastograph®（TEG®）止血分析仪，实时连续测量血栓形成，血小板 - 纤维蛋白相互作用和裂解产生血液止血参数的止血过程。 测量的血液止血参数允许测定肝素诱导的血小板减少II复合物（HiT II）。
-
公开(公告)号：US07732213B2
公开(公告)日：2010-06-08
申请号：US11608174
申请日：2006-12-07
申请人： Eli Cohen , Roslyn Cohen
发明人： Eli Cohen , Roslyn Cohen
IPC分类号： G01N33/86
摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of a patient hemostasis condition.
摘要翻译： 使用止血分析仪，如Thrombelastograph®（TEG®）止血分析仪，实时连续测量血栓形成，血小板 - 纤维蛋白相互作用和裂解产生血液止血参数的止血过程。 测量的血液止血参数允许评估患者止血状况。
-
公开(公告)号：US07179652B2
公开(公告)日：2007-02-20
申请号：US10384345
申请日：2003-03-07
申请人： Eli Cohen , Roslyn Cohen , Roger Carroll
发明人： Eli Cohen , Roslyn Cohen , Roger Carroll
IPC分类号： G01N33/86
CPC分类号： G01N11/162 , G01N11/167 , G01N33/86 , G01N2800/52
摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of platelet inhibition therapy.
摘要翻译： 止血分析仪，如Thrombelastograph（T）（TEG））止血分析仪用于实时连续测量，从初始纤维蛋白形成，血小板 - 纤维蛋白相互作用和裂解产生血液止血参数的止血过程。 测量的血液止血参数允许评估血小板抑制治疗。
-
公开(公告)号：US08008086B2
公开(公告)日：2011-08-30
申请号：US11753071
申请日：2007-05-24
申请人： Eli Cohen , Roslyn Cohen
发明人： Eli Cohen , Roslyn Cohen
CPC分类号： G01N33/86 , G01N2800/52 , G06F19/00
摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of hemostasis therapies including anticoagulation therapies such as direct thrombin inhibition therapies.
摘要翻译： 使用止血分析仪，如Thrombelastograph®（TEG®）止血分析仪，实时连续测量血栓形成，血小板 - 纤维蛋白相互作用和裂解产生血液止血参数的止血过程。 测量的血液止血参数允许评估止血疗法，包括抗凝治疗如直接凝血酶抑制治疗。
-
5.发明申请公开(公告)号：US20090208988A1
公开(公告)日：2009-08-20
申请号：US12430847
申请日：2009-04-27
申请人： Eli Cohen , Roslyn Cohen , Roger C. Carroll
发明人： Eli Cohen , Roslyn Cohen , Roger C. Carroll
IPC分类号： C12Q1/56
CPC分类号： C12Q1/56
摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II).
摘要翻译： 止血分析仪，如Thrombelastograph（T）（TEG））止血分析仪用于实时连续测量，从初始纤维蛋白形成，血小板 - 纤维蛋白相互作用和裂解产生血液止血参数的止血过程。 测量的血液止血参数允许测定肝素诱导的血小板减少II复合物（HiT II）。
-
6.发明授权公开(公告)号：US07524670B2
公开(公告)日：2009-04-28
申请号：US10634553
申请日：2003-08-05
申请人： Eli Cohen , Roslyn Cohen , Roger C. Carroll
发明人： Eli Cohen , Roslyn Cohen , Roger C. Carroll
IPC分类号： C12M1/34
CPC分类号： C12Q1/56
摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II).
摘要翻译： 止血分析仪，如Thrombelastograph（T）（TEG））止血分析仪用于实时连续测量，从初始纤维蛋白形成，血小板 - 纤维蛋白相互作用和裂解产生血液止血参数的止血过程。 测量的血液止血参数允许测定肝素诱导的血小板减少II复合物（HiT II）。
-
7.发明申请公开(公告)号：US20050032142A1
公开(公告)日：2005-02-10
申请号：US10634553
申请日：2003-08-05
申请人： Eli Cohen , Roslyn Cohen , Roger Carroll
发明人： Eli Cohen , Roslyn Cohen , Roger Carroll
CPC分类号： C12Q1/56
摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II).
摘要翻译： 止血分析仪，如Thrombelastograph（T）（TEG））止血分析仪用于实时连续测量，从初始纤维蛋白形成，血小板 - 纤维蛋白相互作用和裂解产生血液止血参数的止血过程。 测量的血液止血参数允许测定肝素诱导的血小板减少II复合物（HiT II）。
-
公开(公告)号：US20080038828A1
公开(公告)日：2008-02-14
申请号：US11753071
申请日：2007-05-24
申请人： Eli Cohen , Roslyn Cohen
发明人： Eli Cohen , Roslyn Cohen
IPC分类号： G01N33/86
CPC分类号： G01N33/86 , G01N2800/52 , G06F19/00
摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of hemostasis therapies including anticoagulation therapies such as direct thrombin inhibition therapies.
摘要翻译： 止血分析仪，如Thrombelastograph（T）（TEG））止血分析仪用于实时连续测量，从初始纤维蛋白形成，血小板 - 纤维蛋白相互作用和裂解产生血液止血参数的止血过程。 测量的血液止血参数允许评估止血疗法，包括抗凝治疗如直接凝血酶抑制治疗。
-
公开(公告)号：US20070184508A1
公开(公告)日：2007-08-09
申请号：US11608174
申请日：2006-12-07
申请人： Eli Cohen , Roslyn Cohen
发明人： Eli Cohen , Roslyn Cohen
IPC分类号： C12Q1/60
摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of a patient hemostasis condition.
摘要翻译： 止血分析仪，如Thrombelastograph（T）（TEG））止血分析仪用于实时连续测量，从初始纤维蛋白形成，血小板 - 纤维蛋白相互作用和裂解产生血液止血参数的止血过程。 测量的血液止血参数允许评估患者止血状况。
-
10.发明申请Protocol for Risk Stratification of Ischemic Events and Optimized Individualized Treatment 有权缺血事件风险分层方案及优化个性化治疗方案公开(公告)号：US20110117586A1
公开(公告)日：2011-05-19
申请号：US13011677
申请日：2011-01-21
申请人： Eli Cohen
发明人： Eli Cohen
CPC分类号： G01N33/86 , G01N2800/52
摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject.
摘要翻译： 使用止血分析仪，如Thrombelastograph®（TEG®）止血分析仪，实时连续测量血栓形成，血小板 - 纤维蛋白相互作用和裂解产生血液止血参数的止血过程。 测量的血液止血参数允许准备个体化的缺血事件风险评估和个体化治疗对象。
-
-
-
-
-
-
-
-
-
搜索结果
72 条记录 (耗时 0.018 秒)
